Citations (89)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Carolyn Young, Susana Pinto, Julian Grosskreutz, Orla Hardiman, Lora L. Clawson, Merit E. Cudkowicz & Jinsy A. Andrews. (2022) Medical therapies for amyotrophic lateral sclerosis-related respiratory decline: an appraisal of needs, opportunities and obstacles. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 23:1-2, pages 66-75.
Read now
Read now
Jinsy A. Andrews, Carlayne E. Jackson, Terry D. Heiman-Patterson, Paolo Bettica, Benjamin Rix Brooks & Erik P. Pioro. (2020) Real-world evidence of riluzole effectiveness in treating amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:7-8, pages 509-518.
Read now
Read now
Imen Kacem, Ikram Sghaier, Sabrine Bougatef, Amina Nasri, Amina Gargouri, Senda Ajroud-Driss & Riadh Gouider. (2020) Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 131-139.
Read now
Read now
Jesus S. Mora, Angela Genge, Adriano Chio, Conrado J. Estol, Delia Chaverri, Maria Hernández, Saúl Marín, Javier Mascias, Gabriel E. Rodriguez, Monica Povedano, Andrés Paipa, Raul Dominguez, Josep Gamez, Maria Salvado, Christian Lunetta, Carlos Ballario, Nilo Riva, Jessica Mandrioli, Alain Moussy, Jean-Pierre Kinet, Christian Auclair, Patrice Dubreuil, Vincent Arnold, Colin D. Mansfield & Olivier Hermine. (2020) Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trial. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 21:1-2, pages 5-14.
Read now
Read now
P. A. McCombe, N. R. Wray & R. D. Henderson. (2017) Extra-motor abnormalities in amyotrophic lateral sclerosis: another layer of heterogeneity. Expert Review of Neurotherapeutics 17:6, pages 561-577.
Read now
Read now
Christian Lunetta, Andrea Lizio, Mario Giovanni Melazzini, Eleonora Maestri & Valeria A. Sansone. (2016) Amyotrophic Lateral Sclerosis Survival Score (ALS-SS): A simple scoring system for early prediction of patient survival. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 93-100.
Read now
Read now
Benoît Marin, Elisa Bianchi, Elisabetta Pupillo, Christian Lunetta, Lucio Tremolizzo, Giancarlo Logroscino, Adriano Chiò, Pierre Marie Preux & Ettore Beghi. (2016) Non-self-sufficiency as a primary outcome measure in ALS trials. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:1-2, pages 77-84.
Read now
Read now
Lucio Tremolizzo, Paolo Messina, Elisa Conti, Gessica Sala, Matteo Cecchi, Luisa Airoldi, Roberta Pastorelli, Elisabetta Pupillo, Monica Bandettini Di Poggio, Massimiliano Filosto, Christian Lunetta, Cristina Agliardi, Franca Guerini, Jessica Mandrioli, Andrea Calvo, Ettore Beghi, Carlo Ferrarese, M.S. Cotelli, M. Corbo, E. Maestri, E. Georgoulopoulou, L. Marzorati, E. Susani, A. Arosio, A. Chiò, G. Fuda & F. Pisa. (2014) Whole-blood global DNA methylation is increased in amyotrophic lateral sclerosis independently of age of onset. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:1-2, pages 98-105.
Read now
Read now
Eleni Georgoulopoulou, Nicola Fini, Marco Vinceti, Marco Monelli, Paolo Vacondio, Giorgia Bianconi, Patrizia Sola, Paolo Nichelli & Jessica Mandrioli. (2013) The impact of clinical factors, riluzole and therapeutic interventions on ALS survival: A population based study in Modena, Italy. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:5-6, pages 338-345.
Read now
Read now
Michele Vitacca, Laura Comini, Giuliano Assoni, Domenico Fiorenza, Sonia Gilè, Palmira Bernocchi & Simonetta Scalvini. (2012) Tele-assistance in patients with amyotrophic lateral sclerosis: long term activity and costs. Disability and Rehabilitation: Assistive Technology 7:6, pages 494-500.
Read now
Read now
Eleni Georgoulopoulou, Marco Vinceti, Francesca Bonvicini, Patrizia Sola, Carlo Alberto Goldoni, Gianfranco De Girolamo, Diana Ferraro, Paolo Nichelli & Jessica Mandrioli. (2011) Changing incidence and subtypes of ALS in Modena, Italy: A 10-years prospective study. Amyotrophic Lateral Sclerosis 12:6, pages 451-457.
Read now
Read now
Articles from other publishers (78)
Erica Tavazzi, Roberto Gatta, Mauro Vallati, Stefano Cotti Piccinelli, Massimiliano Filosto, Alessandro Padovani, Maurizio Castellano & Barbara Di Camillo. (2023) Leveraging process mining for modeling progression trajectories in amyotrophic lateral sclerosis. BMC Medical Informatics and Decision Making 22:S6.
Crossref
Crossref
Dimitrios Tsitsipatis, Krystyna Mazan-Mamczarz, Ying Si, Allison B. Herman, Jen-Hao Yang, Abhishek Guha, Yulan Piao, Jinshui Fan, Jennifer L. Martindale, Rachel Munk, Xiaoling Yang, Supriyo De, Brijesh K. Singh, Ritchie Ho, Myriam Gorospe & Peter H. King. (2022) Transcriptomic analysis of human ALS skeletal muscle reveals a disease-specific pattern of dysregulated circRNAs. Aging 14:24, pages 9832-9859.
Crossref
Crossref
Emily Beswick, Thomas Fawcett, Zack Hassan, Deborah Forbes, Rachel Dakin, Judith Newton, Sharon Abrahams, Alan Carson, Siddharthan Chandran, David Perry & Suvankar Pal. (2022) A systematic review of digital technology to evaluate motor function and disease progression in motor neuron disease. Journal of Neurology 269:12, pages 6254-6268.
Crossref
Crossref
Hongji Sun, Mengxue Wu, Minxin Wang, Xiaomin Zhang & Jia Zhu. (2022) The regulatory role of endoplasmic reticulum chaperone proteins in neurodevelopment. Frontiers in Neuroscience 16.
Crossref
Crossref
Yuri Matteo Falzone, Teuta Domi, Alessandra Mandelli, Laura Pozzi, Paride Schito, Tommaso Russo, Alessandra Barbieri, Raffaella Fazio, Maria Antonietta Volontè, Giuseppe Magnani, Ubaldo Del Carro, Paola Carrera, Andrea Malaspina, Federica Agosta, Angelo Quattrini, Roberto Furlan, Massimo Filippi & Nilo Riva. (2022) Integrated evaluation of a panel of neurochemical biomarkers to optimize diagnosis and prognosis in amyotrophic lateral sclerosis. European Journal of Neurology 29:7, pages 1930-1939.
Crossref
Crossref
N. Ahmed, M.R. Baker & J. Bashford. (2022) The landscape of neurophysiological outcome measures in ALS interventional trials: A systematic review. Clinical Neurophysiology 137, pages 132-141.
Crossref
Crossref
Anna Ostropolets, Xintong Li, Rupa Makadia, Gowtham Rao, Peter R. Rijnbeek, Talita Duarte-Salles, Anthony G. Sena, Azza Shaoibi, Marc A. Suchard, Patrick B. Ryan, Daniel Prieto-Alhambra & George Hripcsak. (2022) Factors Influencing Background Incidence Rate Calculation: Systematic Empirical Evaluation Across an International Network of Observational Databases. Frontiers in Pharmacology 13.
Crossref
Crossref
Mukesh Gautam, Renata Del Carratore, Benjamin Helmold, Alessandra Tessa, Oge Gozutok, Navdeep Chandel, Halil Idrisoglu, Paolo Bongioanni, Roberta Battini & P.Hande Ozdinler. (2022) 2-Year-Old and 3-Year-Old Italian ALS Patients with Novel ALS2 Mutations: Identification of Key Metabolites in Their Serum and Plasma. Metabolites 12:2, pages 174.
Crossref
Crossref
Nancy Tarantino, Ileana Canfora, Giulia Maria Camerino & Sabata Pierno. (2022) Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle. Cells 11:3, pages 415.
Crossref
Crossref
Nuno Jorge Lamas & Laurent Roybon. (2021) Harnessing the Potential of Human Pluripotent Stem Cell-Derived Motor Neurons for Drug Discovery in Amyotrophic Lateral Sclerosis: From the Clinic to the Laboratory and Back to the Patient. Frontiers in Drug Discovery 1.
Crossref
Crossref
Emanuele D’Amico, Giuseppe Grosso, Jeri W. Nieves, Aurora Zanghì, Pam Factor-Litvak & Hiroshi Mitsumoto. (2021) Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis. Nutrients 13:7, pages 2273.
Crossref
Crossref
Alon Kalron, Ibtisam Mahameed, Israela Weiss, Dror Rosengarten, Gingy Ronen Balmor, Moshe Heching & Mordechai Reuven Kramer. (2021) Effects of a 12-week combined aerobic and strength training program in ambulatory patients with amyotrophic lateral sclerosis: a randomized controlled trial. Journal of Neurology 268:5, pages 1857-1866.
Crossref
Crossref
Maria Chiara Trolese, Alessandro Mariani, Mineko Terao, Massimiliano de Paola, Paola Fabbrizio, Francesca Sironi, Mami Kurosaki, Silvia Bonanno, Stefania Marcuzzo, Pia Bernasconi, Francesca Trojsi, Eleonora Aronica, Caterina Bendotti & Giovanni Nardo. (2020) CXCL13/CXCR5 signalling is pivotal to preserve motor neurons in amyotrophic lateral sclerosis. eBioMedicine 62, pages 103097.
Crossref
Crossref
Omar Deeb & Maisa Nabulsi. (2020) Exploring Multiple Sclerosis (MS) and Amyotrophic Lateral Scler osis (ALS) as Neurodegenerative Diseases and their Treatments: A Review Study. Current Topics in Medicinal Chemistry 20:26, pages 2391-2403.
Crossref
Crossref
Erica Tavazzi, Sebastian Daberdaku, Rosario Vasta, Andrea Calvo, Adriano Chiò & Barbara Di Camillo. (2020) Exploiting mutual information for the imputation of static and dynamic mixed-type clinical data with an adaptive k-nearest neighbours approach. BMC Medical Informatics and Decision Making 20:S5.
Crossref
Crossref
Silvia Luotti, Laura Pasetto, Luca Porcu, Valter Torri, Saioa R. Elezgarai, Serena Pantalone, Melania Filareti, Massimo Corbo, Christian Lunetta, Gabriele Mora & Valentina Bonetto. (2020) Diagnostic and prognostic values of PBMC proteins in amyotrophic lateral sclerosis. Neurobiology of Disease 139, pages 104815.
Crossref
Crossref
Pamela A. McCombe, John D. Lee, Trent M. Woodruff & Robert D. Henderson. (2020) The Peripheral Immune System and Amyotrophic Lateral Sclerosis. Frontiers in Neurology 11.
Crossref
Crossref
Maggie A. Kuhn & Lisa Marie Williams. 2020. Neurologic and Neurodegenerative Diseases of the Larynx. Neurologic and Neurodegenerative Diseases of the Larynx
131
141
.
Simon Witzel & Albert Ludolph. (2019) Amyotrophe Lateralsklerose früh erkennen und behandeln. DNP - Der Neurologe & Psychiater 20:2, pages 56-68.
Crossref
Crossref
Satoru Tada, Tatsusada Okuno, Mikito Shimizu, Yoshiki Sakai, Hisae Sumi-Akamaru, Makoto Kinoshita, Kazuya Yamashita, Eri Sanda, Chi-Jing Choong, Akiko Namba, Tsutomu Sasaki, Toru Koda, Kazushiro Takata, Shigeru Miyagawa, Yoshiki Sawa, Yuji Nakatsuji & Hideki Mochizuki. (2019) Single injection of sustained-release prostacyclin analog ONO-1301-MS ameliorates hypoxic toxicity in the murine model of amyotrophic lateral sclerosis. Scientific Reports 9:1.
Crossref
Crossref
Rangariroyashe Hannah Chipika, Eoin Finegan, Stacey Li Hi Shing, Orla Hardiman & Peter Bede. (2019) Tracking a Fast-Moving Disease: Longitudinal Markers, Monitoring, and Clinical Trial Endpoints in ALS. Frontiers in Neurology 10.
Crossref
Crossref
Li-Lan Fu, He-Xiang Yin, Ming-Sheng Liu & Li-Ying Cui. (2019) Study on variation trend of repetitive nerve stimulation waveform in amyotrophic lateral sclerosis. Chinese Medical Journal 132:5, pages 542-550.
Crossref
Crossref
Patrick A. Lewis & Jennifer E. Spillane. 2019. The Molecular and Clinical Pathology of Neurodegenerative Disease. The Molecular and Clinical Pathology of Neurodegenerative Disease
157
191
.
Marlena Wosiski-Kuhn, Miles S. Lyon, James Caress & Carol Milligan. (2019) Inflammation, immunity, and amyotrophic lateral sclerosis: II. immune-modulating therapies. Muscle & Nerve 59:1, pages 23-33.
Crossref
Crossref
Amaya Rando, Diego Pastor, Mari Carmen Viso-León, Anna Martínez, Raquel Manzano, Xavier Navarro, Rosario Osta & Salvador Martínez. (2018) Intramuscular transplantation of bone marrow cells prolongs the lifespan of SOD1G93A mice and modulates expression of prognosis biomarkers of the disease. Stem Cell Research & Therapy 9:1.
Crossref
Crossref
I. S. Bakulin, A. V. Chervyakov, E. I. Kremneva, R. N. Konovalov & M. N. Zakharova. (2019) Structural and Functional Neuroimaging in Amyotrophic Lateral Sclerosis. Human Physiology 44:8, pages 844-854.
Crossref
Crossref
Stephen R. Pfohl, Renaid B. Kim, Grant S. Coan & Cassie S. Mitchell. (2018) Unraveling the Complexity of Amyotrophic Lateral Sclerosis Survival Prediction. Frontiers in Neuroinformatics 12.
Crossref
Crossref
J. Mandrioli, L. Ferri, A. Fasano, E. Zucchi, N. Fini, C. Moglia, C. Lunetta, K. Marinou, N. Ticozzi, G. Drago Ferrante, C. Scialo, G. Sorarù, F. Trojsi, A. Conte, Y. M. Falzone, R. Tortelli, M. Russo, V. A. Sansone, G. Mora, V. Silani, P. Volanti, C. Caponnetto, G. Querin, M. R. Monsurrò, M. Sabatelli, A. Chiò, N. Riva, G. Logroscino, S. Messina & A. Calvo. (2018) Cardiovascular diseases may play a negative role in the prognosis of amyotrophic lateral sclerosis. European Journal of Neurology 25:6, pages 861-868.
Crossref
Crossref
Leila Bond, Kamren Bernhardt, Priyank Madria, Katherine Sorrentino, Hailee Scelsi & Cassie S. Mitchell. (2018) A Metadata Analysis of Oxidative Stress Etiology in Preclinical Amyotrophic Lateral Sclerosis: Benefits of Antioxidant Therapy. Frontiers in Neuroscience 12.
Crossref
Crossref
Christina Schuster, Orla Hardiman & Peter Bede. (2017) Survival prediction in Amyotrophic lateral sclerosis based on MRI measures and clinical characteristics. BMC Neurology 17:1.
Crossref
Crossref
R. Spataro, P. Volanti, D. Lo Coco & V. La Bella. (2017) Marital status is a prognostic factor in amyotrophic lateral sclerosis. Acta Neurologica Scandinavica 136:6, pages 624-630.
Crossref
Crossref
Chang-Hyun Park, Mu-Sun Park, Hyung-Suk Kim, Yun-Yeop Cha, Soon-Joong Kim, Youn-Suk Ko, Min-Seok Oh, Eui-Hyoung Hwang, Byung-Cheul Shin, Chang-Eop Kim & Yun-Kyung Song. (2017) The Exploratory Analysis on the Registry Data of Patients with Low Back Pain Applying Correlation Analysis Method. Journal of Korean Medicine Rehabilitation 27:4, pages 97-109.
Crossref
Crossref
Orla Hardiman, Ammar Al-Chalabi, Adriano Chio, Emma M. Corr, Giancarlo Logroscino, Wim Robberecht, Pamela J. Shaw, Zachary Simmons & Leonard H. van den Berg. (2017) Amyotrophic lateral sclerosis. Nature Reviews Disease Primers 3:1.
Crossref
Crossref
Robert H. Brown & Ammar Al-Chalabi. (2017) Amyotrophic Lateral Sclerosis. New England Journal of Medicine 377:2, pages 162-172.
Crossref
Crossref
Zhouwei Xu, Ashwag Rafea S. Alruwaili, Robert David Henderson & Pamela Ann McCombe. (2017) Screening for cognitive and behavioural impairment in amyotrophic lateral sclerosis: Frequency of abnormality and effect on survival. Journal of the Neurological Sciences 376, pages 16-23.
Crossref
Crossref
Melania Filareti, Silvia Luotti, Laura Pasetto, Mauro Pignataro, Katia Paolella, Paolo Messina, Elisabetta Pupillo, Massimiliano Filosto, Christian Lunetta, Jessica Mandrioli, Giuseppe Fuda, Andrea Calvo, Adriano Chiò, Massimo Corbo, Caterina Bendotti, Ettore Beghi & Valentina Bonetto. (2017) Decreased Levels of Foldase and Chaperone Proteins Are Associated with an Early-Onset Amyotrophic Lateral Sclerosis. Frontiers in Molecular Neuroscience 10.
Crossref
Crossref
Roberta Bonafede & Raffaella Mariotti. (2017) ALS Pathogenesis and Therapeutic Approaches: The Role of Mesenchymal Stem Cells and Extracellular Vesicles. Frontiers in Cellular Neuroscience 11.
Crossref
Crossref
Vincent Meininger, Angela Genge, Leonard H van den Berg, Wim Robberecht, Albert Ludolph, Adriano Chio, Seung H Kim, P Nigel Leigh, Matthew C Kiernan, Jeremy M Shefner, Claude Desnuelle, Karen E Morrison, Susanne Petri, Diane Boswell, Jane Temple, Rajat Mohindra, Matt Davies, Jonathan Bullman, Paul Rees, Arseniy Lavrov, Susanne Abdulla, Cathy Alsop, Francesca Barbieri, Stewart Bates, James D Berry, Stephan A Botez, Gaelle Bruneteau, Andrea Calvo, Rodrigo Refoios Camejo, William Camu, Deven Chauhan, Veronique Danel-Brunaud, Jerzy Daniluk, Annelot Dekker, Alain Destee, Matthew Devine, Stephen DeWall, Johannes Dorst, Giuseppe Fuda, Harutoshi Fujimura, Andreas Funke, Torsten Grehl, Julian Grosskreutz, Usha Gungabissoon, Robert Henderson, Peggy Ho, William Huynh, Saiju Jacob, Raul Juntas-Morales, Byung-Jo Kim, Xenia Kobeleva, Sonja Koerner, Stephen Kolb, Katja Kollewe, Lawrence Korngut, Geraldine Lautrette, Amy Lee, Anthony Lynch, Rami Massie, Genevieve Matte, Darryl Menezes, Stefano Milleri, Linda Nichols, Kazutoshi Nishiyama, Mieko Ogino, Chris Parkinson, Pierre-François Pradat, Tino Prell, Jeffrey Price, Eleanor Ramsey, Thomas M Ringer, Kristiana Salmon, Christen Shoesmith, Marie Helene Soriani, Marloes Stam, Erik Steinberg, Rob Stubbs, Herman Sullivan, Philip Van Damme, Michael van Es, Anne Visser, Mary Lou Watson, Andrea Sylvia Winkler, Lorne Zinman & Margie Zoing. (2017) Safety and efficacy of ozanezumab in patients with amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled, phase 2 trial. The Lancet Neurology 16:3, pages 208-216.
Crossref
Crossref
Andrea Calvo, Cristina Moglia, Christian Lunetta, Kalliopi Marinou, Nicola Ticozzi, Gianluca Drago Ferrante, Carlo Scialo, Gianni Sorarù, Francesca Trojsi, Amelia Conte, Yuri M. Falzone, Rosanna Tortelli, Massimo Russo, Adriano Chiò, Valeria Ada Sansone, Gabriele Mora, Vincenzo Silani, Paolo Volanti, Claudia Caponnetto, Giorgia Querin, Maria Rosaria Monsurrò, Mario Sabatelli, Nilo Riva, Giancarlo Logroscino, Sonia Messina, Nicola Fini & Jessica Mandrioli. (2016) Factors predicting survival in ALS: a multicenter Italian study. Journal of Neurology 264:1, pages 54-63.
Crossref
Crossref
Matthew Nolan, Kevin Talbot & Olaf Ansorge. (2016) Pathogenesis of FUS-associated ALS and FTD: insights from rodent models. Acta Neuropathologica Communications 4:1.
Crossref
Crossref
Albert A. Taylor, Christina Fournier, Meraida Polak, Liuxia Wang, Neta Zach, Mike Keymer, Jonathan D. Glass & David L. Ennist. (2016) Predicting disease progression in amyotrophic lateral sclerosis. Annals of Clinical and Translational Neurology 3:11, pages 866-875.
Crossref
Crossref
R. Tortelli, M. Copetti, F. Panza, A. Fontana, R. Cortese, R. Capozzo, A. Introna, E. D'Errico, S. Zoccolella, S. Arcuti, D. Seripa, I. L. Simone & G. Logroscino. (2016) Time to generalization and prediction of survival in patients with amyotrophic lateral sclerosis: a retrospective observational study. European Journal of Neurology 23:6, pages 1117-1125.
Crossref
Crossref
Pascaline Clerc, Scott Lipnick & Catherine Willett. (2016) A look into the future of ALS research. Drug Discovery Today 21:6, pages 939-949.
Crossref
Crossref
Conceicao Moura Mirian, Rita Carvalho Garbi Novaes Maria, SSP Zago Yuri, Junio Eduardo Emanoel & Augusto Casulari Luiz. (2016) Efficacy and effectiveness of drug treatments in amyotrophic lateral sclerosis: A systematic review with meta-analysis. African Journal of Pharmacy and Pharmacology 10:13, pages 257-269.
Crossref
Crossref
Giovanni Nardo, Maria Chiara Trolese, Massimo Tortarolo, Antonio Vallarola, Mattia Freschi, Laura Pasetto, Valentina Bonetto & Caterina Bendotti. (2016) New Insights on the Mechanisms of Disease Course Variability in ALS from Mutant SOD1 Mouse Models. Brain Pathology 26:2, pages 237-247.
Crossref
Crossref
Magdalena Kuźma-Kozakiewicz, Beata Kaźmierczak, Agnieszka Chudy, Beata Gajewska & Anna Barańczyk-Kuźma. (2016) Alteration of Motor Protein Expression Involved in Bidirectional Transport in Peripheral Blood Mononuclear Cells of Patients with Amyotrophic Lateral Sclerosis. Neurodegenerative Diseases 16:3-4, pages 235-244.
Crossref
Crossref
Mirian Conceicao Moura, Maria Rita Carvalho Garbi Novaes, Emanoel Junio Eduardo, Yuri S. S. P. Zago, Ricardo Del Negro Barroso Freitas & Luiz Augusto Casulari. (2015) Prognostic Factors in Amyotrophic Lateral Sclerosis: A Population-Based Study. PLOS ONE 10:10, pages e0141500.
Crossref
Crossref
Sabrina Paganoni, Chafic Karam, Nanette Joyce, Richard Bedlack & Gregory T. Carter. (2015) Comprehensive rehabilitative care across the spectrum of amyotrophic lateral sclerosis. NeuroRehabilitation 37:1, pages 53-68.
Crossref
Crossref
Becky A. DieboldSusan M.E. SmithYang LiJ. David Lambeth. (2015) NOX2 As a Target for Drug Development: Indications, Possible Complications, and Progress. Antioxidants & Redox Signaling 23:5, pages 375-405.
Crossref
Crossref
Ilaria Caron, Edoardo Micotti, Alessandra Paladini, Giuseppe Merlino, Laura Plebani, Gianluigi Forloni, Michel Modo & Caterina Bendotti. (2015) Comparative Magnetic Resonance Imaging and Histopathological Correlates in Two SOD1 Transgenic Mouse Models of Amyotrophic Lateral Sclerosis. PLOS ONE 10:7, pages e0132159.
Crossref
Crossref
Johann R. Kleinbub, Arianna Palmieri, Alice Broggio, Francesco Pagnini, Enrico Benelli, Marco Sambin & Gianni Sorarù. (2015) Hypnosis-based psychodynamic treatment in ALS: a longitudinal study on patients and their caregivers. Frontiers in Psychology 6.
Crossref
Crossref
P.A. McCombe, C. Pfluger, P. Singh, C.Y.H. Lim, C. Airey & R.D. Henderson. (2015) Serial measurements of phosphorylated neurofilament-heavy in the serum of subjects with amyotrophic lateral sclerosis. Journal of the Neurological Sciences 353:1-2, pages 122-129.
Crossref
Crossref
Marwa Elamin, Peter Bede, Anna Montuschi, Niall Pender, Adriano Chio & Orla Hardiman. (2015) Predicting prognosis in amyotrophic lateral sclerosis: a simple algorithm. Journal of Neurology 262:6, pages 1447-1454.
Crossref
Crossref
Jeffrey Rosenfeld & Michael J. Strong. (2015) Challenges in the Understanding and Treatment of Amyotrophic Lateral Sclerosis/Motor Neuron Disease. Neurotherapeutics 12:2, pages 317-325.
Crossref
Crossref
Marianna Marino, Simonetta Papa, Valeria Crippa, Giovanni Nardo, Marco Peviani, Cristina Cheroni, Maria Chiara Trolese, Eliana Lauranzano, Valentina Bonetto, Angelo Poletti, Silvia DeBiasi, Laura Ferraiuolo, Pamela J. Shaw & Caterina Bendotti. (2015) Differences in protein quality control correlate with phenotype variability in 2 mouse models of familial amyotrophic lateral sclerosis. Neurobiology of Aging 36:1, pages 492-504.
Crossref
Crossref
Hiroshi Mitsumoto, Benjamin R Brooks & Vincenzo Silani. (2014) Clinical trials in amyotrophic lateral sclerosis: why so many negative trials and how can trials be improved?. The Lancet Neurology 13:11, pages 1127-1138.
Crossref
Crossref
Giuseppe Marrali, Federico Casale, Paolina Salamone, Giuseppe Fuda, Cristiana Caorsi, Antonio Amoroso, Maura Brunetti, Gabriella Restagno, Marco Barberis, Davide Bertuzzo, Antonio Canosa, Cristina Moglia, Andrea Calvo & Adriano Chiò. (2014) NADPH oxidase (NOX2) activity is a modifier of survival in ALS. Journal of Neurology 261:11, pages 2178-2183.
Crossref
Crossref
Irene Faravelli, Emanuele Frattini, Agnese Ramirez, Giulia Stuppia, Monica Nizzardo & Stefania Corti. (2014) iPSC-Based Models to Unravel Key Pathogenetic Processes Underlying Motor Neuron Disease Development. Journal of Clinical Medicine 3:4, pages 1124-1145.
Crossref
Crossref
Sabrina Paganoni, Merit Cudkowicz & James D Berry. (2014) Outcome measures in amyotrophic lateral sclerosis clinical trials. Clinical Investigation 4:7, pages 605-618.
Crossref
Crossref
Xiaowei W. Su, James R. Broach, James R. Connor, Glenn S. Gerhard & Zachary Simmons. (2014) Genetic heterogeneity of amyotrophic lateral sclerosis: Implications for clinical practice and research. Muscle & Nerve 49:6, pages 786-803.
Crossref
Crossref
Vedrana Tadic, Tino Prell, Janin Lautenschlaeger & Julian Grosskreutz. (2014) The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Frontiers in Cellular Neuroscience 8.
Crossref
Crossref
Sara Cimini, Milena Rizzardini, Gloria Biella & Lavinia Cantoni. (2014) Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis. Journal of Neurochemistry 129:3, pages 413-425.
Crossref
Crossref
Y. Wu, K. Satkunendrarajah & M.G. Fehlings. (2014) Riluzole improves outcome following ischemia–reperfusion injury to the spinal cord by preventing delayed paraplegia. Neuroscience 265, pages 302-312.
Crossref
Crossref
Franco Franchignoni, Gabriele Mora, Andrea Giordano, Paolo Volanti & Adriano Chiò. (2013) Evidence of multidimensionality in the ALSFRS-R Scale: a critical appraisal on its measurement properties using Rasch analysis. Journal of Neurology, Neurosurgery & Psychiatry 84:12, pages 1340-1345.
Crossref
Crossref
Antonio Musarò. (2013) Understanding ALS: new therapeutic approaches. FEBS Journal 280:17, pages 4315-4322.
Crossref
Crossref
Jakob Maximilian Moser, Paolo Bigini & Thomas Schmitt-John. (2013) The wobbler mouse, an ALS animal model. Molecular Genetics and Genomics 288:5-6, pages 207-229.
Crossref
Crossref
Marwa ElaminPeter BedeSusan ByrneNorah JordanLaura GallagherBrona WynneCaoimhe O’BrienJulie PhukanCatherine LynchNiall PenderOrla Hardiman. (2013) Cognitive changes predict functional decline in ALS. Neurology 80:17, pages 1590-1597.
Crossref
Crossref
Adriano Chiò & Gabriele Mora. (2013) The final chapter of the ALS lithium saga. The Lancet Neurology 12:4, pages 324-325.
Crossref
Crossref
F. Baumann, R.D. Henderson, P.G. Ridall, A.N. Pettitt & Pamela A. McCombe. (2012) Use of Bayesian MUNE to show differing rate of loss of motor units in subgroups of ALS. Clinical Neurophysiology 123:12, pages 2446-2453.
Crossref
Crossref
Mauro CozzolinoMaria Grazia PesaresiValeria GerbinoJulian GrosskreutzMaria Teresa Carrì. (2012) Amyotrophic Lateral Sclerosis: New Insights into Underlying Molecular Mechanisms and Opportunities for Therapeutic Intervention. Antioxidants & Redox Signaling 17:9, pages 1277-1330.
Crossref
Crossref
C. Sámano, S.E. Nasrabady & A. Nistri. (2012) A study of the potential neuroprotective effect of riluzole on locomotor networks of the neonatal rat spinal cord in vitro damaged by excitotoxicity. Neuroscience 222, pages 356-365.
Crossref
Crossref
Kin Y. Mok, Georgios Koutsis, Lucia V. Schottlaender, James Polke, Marios Panas & Henry Houlden. (2012) High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobiology of Aging 33:8, pages 1851.e1-1851.e5.
Crossref
Crossref
G. Diane Shelton, Gayle C. Johnson, Dennis P. O'Brien, Martin L. Katz, Jill P. Pesayco, Brian J. Chang, Andrew P. Mizisin & Joan R. Coates. (2012) Degenerative myelopathy associated with a missense mutation in the superoxide dismutase 1 (SOD1) gene progresses to peripheral neuropathy in Pembroke Welsh Corgis and Boxers. Journal of the Neurological Sciences 318:1-2, pages 55-64.
Crossref
Crossref
Silvia Sorce, Karl-Heinz Krause & Vincent Jaquet. (2012) Targeting NOX enzymes in the central nervous system: therapeutic opportunities. Cellular and Molecular Life Sciences 69:14, pages 2387-2407.
Crossref
Crossref
Caterina Bendotti, Marianna Marino, Cristina Cheroni, Elena Fontana, Valeria Crippa, Angelo Poletti & Silvia De Biasi. (2012) Dysfunction of constitutive and inducible ubiquitin-proteasome system in amyotrophic lateral sclerosis: Implication for protein aggregation and immune response. Progress in Neurobiology 97:2, pages 101-126.
Crossref
Crossref
P. Milani, S. Gagliardi, P. Bongioanni, G.S. Grieco, M. Dezza, M. Bianchi, E. Cova, M. Ceroni & C. Cereda. (2012) Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. Journal of the Neurological Sciences 313:1-2, pages 75-78.
Crossref
Crossref
Orla Hardiman, Leonard H. van den Berg & Matthew C. Kiernan. (2011) Clinical diagnosis and management of amyotrophic lateral sclerosis. Nature Reviews Neurology 7:11, pages 639-649.
Crossref
Crossref
A. ChiòA. CanosaS. GalloS. CammarosanoC. MogliaG. FudaA. CalvoM. Gabriele. (2011) ALS clinical trials. Neurology 77:15, pages 1432-1437.
Crossref
Crossref